PubMed Health⌕ Search

Biomedical subjects

G Carpinito

Publications and source records attributed to G Carpinito.

7 recordsLinked to original sources
PubMed1994

Trial of intravesical versus extravesical ureteroneocystostomy in renal transplant recipients.

We carried out a trial to evaluate the complication rate of intravesical (LP) versus extravesical (Lich) ureteroneocystostomy in recipients of renal transplantation. Ureteric stenosis was the predominant complication in the LP technique, which was more difficult to correct. Complications by the Lich technique were urinary leaks, which were managed successfully by prolonged bladder drainage. We conclude that the Lich technique is simpler to perform and avoids the complication of ureteric stenosis, and should therefore be the procedure of choice for ureteric implantation in recipients of renal transplants.

Adult↗
PubMed1992

Successful renal transplantation in a patient with systemic sarcoidosis and renal failure due to focal glomerulosclerosis.

In 1987, a patient presented with pulmonary sarcoidosis and progressive renal failure. Percutaneous renal biopsy showed focal glomerular sclerosis (FGS). Over the subsequent 4-year period, her renal failure progressed to require hemodialysis. During this time, her pulmonary sarcoidosis was treated with daily corticosteroid therapy and she remained in clinical remission. The patient received a one-haplotype-identical living-related renal transplant from her mother. The patient is now 25 months posttransplant with a serum creatinine of 106 mumol/L (1.2 mg/dL). Her sarcoidosis continues to be in clinical remission. In this report, we review the rare association of a primary glomerular lesion causing renal failure in patients with sarcoidosis. In addition, we detail the first successful renal transplant in such a patient.

Adult↗
PubMed1988

Autolymphocyte therapy.

Autolymphocyte therapy is medical treatment based upon the infusion of autologous lymphocytes that have been immunized or modulated in vitro. These infused cells subsequently provoke fundamental immunobiologic changes in the host. We suggest that autolymphocyte therapy might be a useful approach in the treatment and prophylaxis of several diseases.

Autoimmune Diseases↗